The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

  • Funded by Oxford University Clinical Research Unit (OUCRU)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    Oxford University Clinical Research Unit (OUCRU)
  • Principal Investigator

    N/A

  • Research Location

    Viet Nam
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

In this observational study, our primary aim is to utilize the expertise we have developed in OUCRU Vietnam to develop dynamic models that predict disease progression using real-time, longitudinal clinico-physiological data and specific blood biomarkers. Achieving this requires research in early infection and across the disease severity spectrum. In many countries, this is difficult due to high burden of severe cases. In Vietnam, the early identification of SARS-CoV-2 infections is routine due to a highly efficient test, trace and quarantine system. At OUCRU Vietnam, in collaboration with Oxford UK, we are using point-of-care ultrasound and physiological monitoring via simple low-cost wearable devices to develop artificial intelligence (AI) systems to better manage critically ill patients. In this project, we intend to use conventional statistical techniques and AI to develop dynamic predictive models that will enable identification patients at risk of disease progression in COVID-19. We will build on our expertise using data from wearable devices, point-of-care heart and lung ultrasound, and specific blood biomarkers.